HTScience
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 3
About HTScience
, dba HTScience, is a pre-clinical and life science research and development service provider. The company has subsidiaries in Foshan and Shenzhen, with a laboratory area of over 10,000 square meters, also has a core team of scientists from universities and research and development institutions such as South China University of Technology and National University of Singapore. At the same time, the company has provided technical services for Baiyunshan Pharmaceutical, Microchip Bio and other institutions and manufacturers, and has successfully submitted several IND applications to USFDA and CFDA, and entered clinical trials. The company specializes in pre-clinical research and development services for pharmaceuticals, medical devices, gene and cell therapies. It uses technologies such as gene editing, surgical modeling and chemical diet induction to construct animal models of human diseases, which can simulate the development of clinical diseases and provide a tool platform for biopharmaceutical research and development. HTScience generates revenue by providing R&D services such as high-throughput disease target screening, gene-edited cell line construction, disease animal model construction, pharmacology, drug metabolism and safety evaluation (Non-GLP).
Who invested in HTScience
3 investors across 2 rounds
See all investors in HTScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HTScience
Who invested in HTScience?
HTScience has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HTScience raised?
HTScience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HTScience last raise money?
HTScience's most recent round on record is a Series A, in Aug 2023.
What does HTScience do?
, dba HTScience, is a pre-clinical and life science research and development service provider.
Where is HTScience headquartered?
HTScience is headquartered in Guangzhou, China.
Which VCs invest in companies like HTScience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at HTScience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like HTScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.